Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer

Currently, the same first-line chemotherapy is administered to almost all patients suffering from primary ovarian cancer. The high recurrence rate emphasizes the need for precise drug treatment in primary ovarian cancer. Being crucial in ovarian cancer progression and chemotherapeutic resistance, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dötzer, Katharina, Schlüter, Friederike, von Koch, Franz Edler, Brambs, Christine E., Anthuber, Sabine, Frangini, Sergio, Czogalla, Bastian, Burges, Alexander, Werner, Jens, Mahner, Sven, Mayer, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999332/
https://www.ncbi.nlm.nih.gov/pubmed/33809043
http://dx.doi.org/10.3390/biomedicines9030289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999332/
https://www.ncbi.nlm.nih.gov/pubmed/33809043
http://dx.doi.org/10.3390/biomedicines9030289

Ejemplares similares